Evolution of Anti-SARS-CoV-2 IgG Antibody and IgG Avidity Post Pfizer and Moderna mRNA Vaccinations

Kevin P. Bliden, Tiancheng Liu, Deepika Sreedhar, Jessica Kost, Jessica Hsiung, Su Zhao, Dingying Shan, Abira Usman, Naval Walia, Alastair Cho, Christophe Jerjian, Udaya S. Tantry, Paul A. Gurbel, Meijie Tang, Hongjie Dai
doi: https://doi.org/10.1101/2021.06.28.21259338

Article usage

Article usage: July 2021 to December 2024

AbstractFullPdf
Jul 20211395110381
Aug 2021967169270
Sep 202168218150
Oct 202139318106
Nov 2021351116133
Dec 20212862998
Jan 20227293075
Feb 2022571434
Mar 2022315732
Apr 2022821734
May 2022741521
Jun 2022501113
Jul 20224509
Aug 202289825
Sep 202272217
Oct 2022581112
Nov 2022431616
Dec 202234717
Jan 202351916
Feb 2023421817
Mar 2023391218
Apr 202366927
May 2023481317
Jun 202339136
Jul 2023501010
Aug 2023442315
Sep 202352158
Oct 202329158
Nov 20231027821
Dec 2023441212
Jan 202434419
Feb 202418913
Mar 2024321218
Apr 2024292432
May 2024322013
Jun 2024291617
Jul 2024201312
Aug 2024241511
Sep 2024451616
Oct 2024311210
Nov 2024361715
Dec 2024291718
Back to top
Posted July 02, 2021.
Download PDF
Data/Code
Email
Evolution of Anti-SARS-CoV-2 IgG Antibody and IgG Avidity Post Pfizer and Moderna mRNA Vaccinations
Kevin P. Bliden, Tiancheng Liu, Deepika Sreedhar, Jessica Kost, Jessica Hsiung, Su Zhao, Dingying Shan, Abira Usman, Naval Walia, Alastair Cho, Christophe Jerjian, Udaya S. Tantry, Paul A. Gurbel, Meijie Tang, Hongjie Dai
medRxiv 2021.06.28.21259338; doi: https://doi.org/10.1101/2021.06.28.21259338
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area